Stocks and InvestingStocks and Investing
Fri, May 27, 2022
Thu, May 26, 2022
Wed, May 25, 2022
Tue, May 24, 2022

Madhu Kumar Maintained (SNDX) at Strong Buy with Decreased Target to $40 on, May 24th, 2022


Published on 2024-10-27 21:16:24 - WOPRAI, Madhu Kumar
  Print publication without navigation


Madhu Kumar of Goldman Sachs, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy with Decreased Target from $51 to $40 on, May 24th, 2022.

Madhu has made no other calls on SNDX in the last 4 months.



There is 1 other peer that has a rating on SNDX. Out of the 1 peers that are also analyzing SNDX, 0 agree with Madhu's Rating of Hold.



This is the rating of the analyst that currently disagrees with Madhu


  • Edward White of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $31 on, Monday, April 11th, 2022